Status:

TERMINATED

Assessment of Revascularization Versus Conservative Treatment in Heart Transplant Patients for a Clinical Event Reduction

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Conditions:

Heart-lung Transplant Rejection

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

The aim of the study is to compare optimal medical therapy alone versus percutaneous coronary intervention on top of medical therapy in the setting of heart transplant recipient coronary artery diseas...

Detailed Description

The hypothesis of the study is the superiority of the interventional management over medical therapy alone in preventing the occurrence of the primary endpoint of the study assessed 1 year after rando...

Eligibility Criteria

Inclusion

  • Patients ≥ 18 years old
  • Heart transplant recipient
  • Stable clinical situation
  • One or several non-critical coronary stenoses (≥ 50% et ≤ 75% visually or QCA-assessed diameter stenosis) considered as adequate for coronary stenting by the operator
  • Left ventricular ejection fraction ≥ 40%
  • Informed consentement signed by the patient

Exclusion

  • Acute coronary syndrome
  • In-stent restenosis
  • Proof of an extensive myocardial ischemia (≥ 7/17 segments ASE model)
  • Coronary stenosis considered as critical by the operators with slow flow
  • ACC/AHA Class IA indication for revascularization :
  • vessel disease with left ventricular dysfunction
  • Left main stenosis
  • Severe proximal LAD stenosis
  • Contra-indication to dual antiplatelet therapy
  • Decompensated heart failure at the time of randomization
  • Pregnant or breast-feeding women- Patients participating to another clinical research within 30 days before randomization- life expectancy \< 1 y
  • Patients unable to observe strict medical therapy and follow-up within 1 year after randomization

Key Trial Info

Start Date :

February 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2015

Estimated Enrollment :

6 Patients enrolled

Trial Details

Trial ID

NCT01795729

Start Date

February 1 2013

End Date

February 1 2015

Last Update

October 14 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Pitié Salpetriere university Hospital - Cardiology

Paris, France, 75013